Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re NAV and Interim Dividend

15 Oct 2020 16:45

RNS Number : 2550C
Maven Income & Growth VCT PLC
15 October 2020
 

Maven Income and Growth VCT PLC

 

Net Asset Value (NAV) and Interim Dividend

 

The Directors of Maven Income and Growth VCT PLC (the Company) confirm that the unaudited NAV of the Company as at 31 August 2020 was 44.35p per Ordinary Share.

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration the availability of surplus revenue, the realisation of capital gains, the adequacy of distributable reserves and the VCT qualifying level. These factors are kept under close and regular review by the Board and the Manager, both of whom recognise the importance of tax-free distributions to Shareholders.

 

In light of the recent realisation activity, the Board is pleased to declare that, in respect of the year ending 28 February 2021, an interim dividend of 1.00p per Ordinary Share will be paid on 20 November 2020 to Shareholders on the register at close of business on 23 October 2020. Since the Company's launch, and after receipt of this latest dividend, 99.91p per share will have been distributed in tax-free dividends. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

Dividend Investment Scheme (DIS)

 

Your Company has in place a DIS, through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority granted by Shareholders at AGMs. On 26 March 2020, the Board announced that the DIS had been suspended due to the volatility in financial markets caused by the COVID-19 pandemic, with the payment of the final dividend for the year ended 29 February 2020, on 31 July 2020, being made by either cheque or bank transfer using existing mandate instructions.

 

The Directors have resolved to re-introduce the DIS with immediate effect. This means that, unless they advise the Company otherwise, those Shareholders who had previously elected to participate in the DIS will revert to receiving new shares with effect from 20 November 2020, being the payment date of the declared interim dividend. Shareholders who have not previously applied to participate in the DIS but wish to do so in respect of the interim dividend payable on 20 November 2020, should ensure that a mandate form, or CREST instruction if appropriate, is received by the Registrar, Link Market Services, prior to the dividend election date of 6 November 2020. Shares issued under the DIS should, subject to an individual Shareholder's particular circumstances, qualify for VCT tax reliefs applicable for the tax year in which they are allotted. The terms & conditions of the scheme, together with a mandate form, are available from the Company's website at: www.mavencp.com/migvct.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its interim results for the six months ended 31 August 2020 has been, or will be, notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

15 October 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDZMMGKKDGGZM
Date   Source Headline
24th Aug 20153:33 pmRNSStatement re Dividend Investment Scheme
17th Jul 20154:33 pmRNSIssue of Equity
17th Jul 201510:42 amRNSNet Asset Value(s)
9th Jul 20154:23 pmRNSNet Asset Value(s)
9th Jul 20154:16 pmRNSDirectorate Change
9th Jul 20154:11 pmRNSResult of AGM
5th Jun 20154:35 pmRNSAnnual Financial Report
6th May 20152:26 pmRNSStatement re NAV & Proposed Dividend Declaration
13th Apr 20153:08 pmRNSIssue of Equity
27th Mar 20154:46 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
20th Mar 20154:52 pmRNSIssue of Equity
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201510:41 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
20th Feb 20152:44 pmRNSIssue of Equity
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
28th Jan 20152:21 pmRNSNet Asset Value(s)
21st Jan 20153:47 pmRNSStatement re Offers and Related Party Transactions
20th Jan 20159:48 amRNSStatement re Offers for Subscription
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
28th Nov 20144:22 pmRNSTransaction in Own Shares
28th Oct 20147:00 amRNSHalf Yearly Report
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20149:57 amRNSNet Asset Value(s)
3rd Oct 20144:20 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
5th Aug 20144:05 pmRNSTransaction in Own Shares
4th Aug 20144:28 pmRNSTransaction in Own Shares
31st Jul 20143:51 pmRNSTransaction in Own Shares
11th Jul 20142:46 pmRNSInterim Management Statement
10th Jul 20142:06 pmRNSResult of AGM
4th Jul 20144:28 pmRNSReplacement re Issue of Equity
2nd Jul 20149:45 amRNSIssue of Equity
6th Jun 20144:48 pmRNSAnnual Financial Report
28th May 20145:07 pmRNSOffer for Subscription Update
21st May 20149:55 amRNSNet Asset Value(s)
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:43 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 20144:11 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:27 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
17th Feb 201412:31 pmRNSDirector/PDMR Shareholding
10th Feb 20146:02 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:16 pmRNSIssue of Equity
23rd Jan 20142:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.